FOUND HEALTH

Found launched in 2020 as the GLP-1 revolution was quietly brewing. The founders identified a gap between people who needed medically supervised weight management and the fragmented system of clinics, insurance, and specialists that made access nearly impossible.

They built a telehealth platform that combined licensed physicians, personalized treatment plans including medication where appropriate, and continuous behavioral coaching — all in one membership. Early traction was strong because they targeted a problem that was enormous and underserved.

Monthly membership model. Members pay a recurring fee for access to a care team that includes physicians, registered dietitians, and health coaches.

The platform manages the full weight management protocol: initial assessment, treatment plan, prescription fulfillment for medications including GLP-1s where clinically appropriate, and ongoing check-ins. Revenue comes from memberships plus potential pharmacy revenue from medication management.

["Personalized weight management programs", "GLP-1 prescription management and support", "Behavioral coaching and dietary guidance", "Ongoing care team access via mobile app"]

Growth through performance marketing targeting people searching for weight loss solutions, combined with employer health benefits partnerships. Found targets the commercially insured population that has historically been underserved by traditional weight management programs.

The GLP-1 tailwind has dramatically lowered customer acquisition friction — people come to them pre-convinced that medical weight management works.

Medication access and insurance coverage. GLP-1 drugs like Wegovy can cost $1,000+ per month without insurance, and many plans still exclude them.

Found's business model works best when patients can actually get and afford the medications that drive results. Formulary changes, supply constraints, and the ongoing battle for insurance coverage create significant operational uncertainty.

GV (Google Ventures), General Catalyst, Forerunner Ventures, and others backed Found's growth. The company attracted investor interest from firms betting on the digitization of chronic condition management.